Catherine E. Charron

544 total citations
16 papers, 410 citations indexed

About

Catherine E. Charron is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine E. Charron has authored 16 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine E. Charron's work include Asthma and respiratory diseases (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Catherine E. Charron is often cited by papers focused on Asthma and respiratory diseases (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Catherine E. Charron collaborates with scholars based in United Kingdom, United States and Japan. Catherine E. Charron's co-authors include Kazuhiro Ito, Ian M. Adcock, Peter J. Barnes, Masako To, Kenichi Akashi, Hidenori Wada, Yoshiki Kobayashi, Christos Rossios, Dai Takagi and P. Lambin and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and CHEST Journal.

In The Last Decade

Catherine E. Charron

16 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Charron United Kingdom 10 157 148 124 71 53 16 410
Charles N. Serhan United States 7 119 0.8× 174 1.2× 48 0.4× 179 2.5× 51 1.0× 7 577
Kouichi Fukunaga Japan 6 129 0.8× 74 0.5× 80 0.6× 53 0.7× 51 1.0× 7 328
Helen Galczenski United States 9 187 1.2× 171 1.2× 59 0.5× 113 1.6× 35 0.7× 9 438
Melanie Eggermont Belgium 11 74 0.5× 110 0.7× 41 0.3× 127 1.8× 25 0.5× 14 335
Jean‐Christophe Bérubé Canada 11 122 0.8× 162 1.1× 93 0.8× 91 1.3× 67 1.3× 16 408
Tracy Clarke United States 6 95 0.6× 119 0.8× 51 0.4× 43 0.6× 14 0.3× 7 426
Beilei Zhao China 11 53 0.3× 197 1.3× 77 0.6× 30 0.4× 40 0.8× 20 430
Alysia Kern Lovgren United States 6 69 0.4× 171 1.2× 137 1.1× 39 0.5× 93 1.8× 6 501
Rhett Cummings United States 8 127 0.8× 401 2.7× 92 0.7× 190 2.7× 58 1.1× 8 617
James Root Sweden 7 63 0.4× 116 0.8× 147 1.2× 98 1.4× 46 0.9× 10 414

Countries citing papers authored by Catherine E. Charron

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Charron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Charron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Charron more than expected).

Fields of papers citing papers by Catherine E. Charron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Charron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Charron. The network helps show where Catherine E. Charron may publish in the future.

Co-authorship network of co-authors of Catherine E. Charron

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Charron. A scholar is included among the top collaborators of Catherine E. Charron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Charron. Catherine E. Charron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Charron, Catherine E., Kazuhiro Ito, Simon Lea, et al.. (2017). RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation. European Respiratory Journal. 50(4). 1700188–1700188. 39 indexed citations
3.
Onions, Stuart, Kazuhiro Ito, Catherine E. Charron, et al.. (2016). Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma. Journal of Medicinal Chemistry. 59(5). 1727–1746. 17 indexed citations
4.
Thomson, Neil C., Catherine E. Charron, Rekha Chaudhuri, et al.. (2015). Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma. Pulmonary Pharmacology & Therapeutics. 31. 1–8. 30 indexed citations
5.
Cass, Lindsey, Kazuhiro Ito, Catherine E. Charron, et al.. (2013). Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients. European Respiratory Journal. 42(Suppl 57). 1971–1971. 4 indexed citations
7.
Kobayashi, Yoshiki, Hidenori Wada, Christos Rossios, et al.. (2013). A novel macrolide/fluoroketolide, solithromycin (CEM‐101), reverses corticosteroid insensitivity via phosphoinositide 3‐kinase pathway inhibition. British Journal of Pharmacology. 169(5). 1024–1034. 65 indexed citations
8.
To, Masako, Satoshi Yamamura, Kenichi Akashi, et al.. (2011). Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7. CHEST Journal. 141(5). 1233–1242. 36 indexed citations
9.
Charron, Catherine E., Matthew Coates, Kazuhiro Ito, et al.. (2011). Superior Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Roduction In Macrophages. A3088–A3088. 3 indexed citations
10.
Charron, Catherine E., Matthew Coates, & Kazuhiro Ito. (2011). Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, On Pro-Inflammatory Cytokine Production In Epithelial Cells Isolated From Asthma And COPD. A1383–A1383. 2 indexed citations
11.
Charron, Catherine E., Matthew Coates, & Kazuhiro Ito. (2011). Effects Of RV1088, A Novel Narrow Spectrum Kinase Inhibitor, On Pro-Inflammatory Cytokine Production In Epithelial Cells Isolated From Asthma And COPD. A2817–A2817. 2 indexed citations
12.
Charron, Catherine E., Pai-Chien Chou, Vaibhav Kumar, et al.. (2009). Hypoxia-inducible Factor 1α Induces Corticosteroid-insensitive Inflammation via Reduction of Histone Deacetylase-2 Transcription. Journal of Biological Chemistry. 284(52). 36047–36054. 44 indexed citations
13.
Ito, Kazuhiro, Catherine E. Charron, & Ian M. Adcock. (2007). Impact of protein acetylation in inflammatory lung diseases. Pharmacology & Therapeutics. 116(2). 249–265. 64 indexed citations
14.
Embury, Jennifer E., Catherine E. Charron, Anatoly E. Martynyuk, et al.. (2006). PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pahenu2 mice. Brain Research. 1127(1). 136–150. 24 indexed citations
15.
Ito, Kazuhiro, et al.. (2006). Mode of Glucocorticoid Actions in Airway Disease. The Scientific World JOURNAL. 6. 1750–1769. 41 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026